EIN 81-1547477

Oxfendazole Development Group

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2016
Most recent tax filings
2023-12-01
Description
Nonprofit developing pharmaceuticals to eliminate neglected tropical diseases, with focus on oxfendazole. Conducts nonclinical work and clinical studies. Located in Blue Bell, PA.
Total revenues
$58,517
2023
Total expenses
$604,664
2023
Total assets
$1,146,889
2023
Num. employees
0
2023

Program areas at Oxfendazole Development Group

scientific work toward the approval of oxfendazole for human use; nonclinical scientific studies and scientific consultant fees

Who funds Oxfendazole Development Group

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Silicon Valley Community Foundation (SVCF)Health$1,600,000
AmazonSmile FoundationGeneral Support$63

Personnel at Oxfendazole Development Group

NameTitleCompensation
Hector Hugo Garcia, M.D., PH.D.Board Member$0
Ellen CoddTreasurer$0
R John HortonPresident Board Member$0
Timothy GearySecretary Board Member$0

Financials for Oxfendazole Development Group

RevenuesFYE 12/2023
Total grants, contributions, etc.$8,471
Program services$0
Investment income and dividends$49,898
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$148
Total revenues$58,517

Form 990s for Oxfendazole Development Group

Fiscal year endingDate received by IRSFormPDF link
2023-122024-04-16990View PDF
2022-122023-05-13990View PDF
2018-122019-08-09990View PDF
2017-122018-07-16990View PDF
Data update history
May 20, 2024
Posted financials
Added Form 990 for fiscal year 2023
December 24, 2023
Received grants
Identified 1 new grant, including a grant for $1,600,000 from Silicon Valley Community Foundation (SVCF)
October 22, 2023
Updated personnel
Identified 6 new personnel
July 7, 2023
Posted financials
Added Form 990 for fiscal year 2022
June 30, 2023
Updated personnel
Identified 4 new personnel
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealth
Characteristics
Conducts researchState / local levelTax deductible donationsNo full-time employees
General information
Address
736 Cathcart Rd
Blue Bell, PA 19422
Metro area
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
County
Montgomery County, PA
Website URL
oxfendazoledevelopmentgroup.org/ 
Phone
(484) 557-3831
IRS details
EIN
81-1547477
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2016
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H00: Medical Research: General
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when Oxfendazole Development Group has new information, or want to find more organizations like Oxfendazole Development Group?

Create free Cause IQ account